Aquatic Capital Management’s Rigel Pharmaceuticals RIGL Stock Holding History

Aquatic Capital Management’s Portfolio RIGL Stock Details RIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$674K	Sell	17,233 -25,549	-60%	-$788K	0.02%	692
2026 Q1	$1.16M	Buy	+42,782	New	+$1.44M	0.03%	528
2025 Q4	–	Sell	-7,775	Closed	-$220K	–	1715
2025 Q3	$220K	Buy	7,775 +2,751	+55%	+$82.3K	﹤0.01%	1076
2025 Q2	$94.1K	Buy	5,024 +4,896	+3,825%	+$92.8K	﹤0.01%	1098
2025 Q1	$2.3K	Buy	+128	New	+$2.6K	﹤0.01%	1206
2022 Q3	–	Sell	-120	Closed	-$1K	–	1490
2022 Q2	$1K	Buy	+120	New	+$2.41K	﹤0.01%	1133
2022 Q1	–	Sell	-1,320	Closed	-$35K	–	1452
2021 Q4	$35K	Buy	+1,320	New	+$39.8K	0.07%	418

Other funds holding RIGL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Aquatic Capital Management's RIGL Position: Q2 2026 in Review

Aquatic Capital Management reduced its Rigel Pharmaceuticals (RIGL) stake by 60% in Q2 2026, selling an estimated $788K and leaving 17,233 shares worth $674K. The position accounts for 0.02% of the portfolio, ranked #692.

Aquatic Capital Management first reported a position in RIGL in Q4 2021 and has held it in 7 quarters since. The position peaked at $1.16M in Q1 2026. 156 funds tracked by Wall St. Rank hold RIGL as of Q2 2026.

Aquatic Capital Management held 17,233 shares of Rigel Pharmaceuticals worth $674K as of Q2 2026.
Aquatic Capital Management sold 25,549 Rigel Pharmaceuticals shares in Q2 2026, an estimated $788K.
Rigel Pharmaceuticals made up 0.02% of Aquatic Capital Management's portfolio in Q2 2026, its #692 holding.
Aquatic Capital Management first reported a position in Rigel Pharmaceuticals in Q4 2021 and has held it in 7 quarters since.
Aquatic Capital Management's Rigel Pharmaceuticals position peaked at $1.16M in Q1 2026.
156 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.